Andelyn Biosciences is a contract development and manufacturing organization (CDMO) that provides process development, analytical services, and cGMP manufacturing for biologics and cell & gene therapy products.
The company supports viral vectors, plasmids, and other complex biologics across preclinical through commercial phases, and offers quality, regulatory, and supply chain capabilities to biopharmaceutical partners.
Leadership & Board
Current Number of Employees284
Current LinkedIn Followers11,199
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$5M
Total Amount Raised$5M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Andelyn Biosciences had 284 employees as of May 25, 2026. The number of employees increased by 5 (1.79%) week-over-week.
284Latest Employee Count
5(1.79%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Andelyn Biosciences had 11,199 followers as of May 25, 2026. The number of followers increased by 88 (0.79%) week-over-week.
11,199Latest Followers Count
88(0.79%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.